Merck’s experimental Covid pill should be accompanied by other treatments - expert
Company’s molnupiravir pill has been hailed as potential breakthrough
Covid-19 antiviral pill halves risk of hospitalisation and death – Merck
Pharmaceuticals company developing twice-daily pill for patients diagnosed with virus
Merck takes €141.5m charge after discontinuing development of Covid drug
US regulators said early in 2021 results from small study weren’t sufficient to seek clearance for drug
Vaccine giant Merck pulls plug on Covid trials
Two vaccine candidates fail to deliver strong enough results to challenge rivals
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
The GlossOpens in new window
Read the digital edition of The Gloss magazine now
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices